New and free- our free ebook about the kidney, it’s function, kidney disease & the treatments for kidney disease including dialysis & transplant. Visit our website at www.kidney-solutions & when you see this picture pop up, put in your email & we will send the book to your email
A patient preparing for regularly taking medication for 3 weeks during a trip. It is absolutely important to take medications on time with no exceptions or excuses. Doesn’t matter if you are at home, at work or on a trip.
After being diagnosed with genetic FSGS, a form of kidney disease caused by a mutation of the APOL1 gene, Therochelle decided to undergo genetic testing. Listen to Therochelle’s story: https://t.co/zXXZU2yKkZ
Thank you @Vertex for making our APOL1 patient video series possible.
Learn about APOL1 mediated kidney disease from Armani’s personal experience
Emani's Journey | Caring for APOL1-Mediated Kidney Disease | AKF https://t.co/SASjLvNDGo via @YouTube
There is a treatment in clinical trial for kidney disease due to APOL1 genetic variants. We hope the ongoing phase 3 trial is positive because it will help many Nigerians and West Africans. Read our blog post on this cause of kidney disease https://t.co/KZIt1lTvP0
APOL1 variants cause kidney disease and accelerate progression of kidney disease. In one study, the frequency of APOL1 high-risk genotype was 6.2%, which varied by ethnic group: Hausa/Fulani (2.1%), Igbo (49.1%), and Yoruba (14.5%). @nigeriahealthwatch @healthevangelist @docneto1
In a phase 2a study, 16 participants with APOL1 nephropathy received inaxaplin, an inhibitor of APOL1 channel function. Among 13 evaluable participants, the mean reduction in proteinuria was 47.6% at week 13. https://t.co/QHcvbYEmiz
#nephrology#CKD
This article describes the science behind a study on the use of inaxaplin in patients with focal segmental glomerulosclerosis who have two risk alleles of the gene APOL1. https://t.co/dlx2P2v1mO
This article describes the science behind a study on the use of inaxaplin in patients with focal segmental glomerulosclerosis who have two risk alleles of the gene APOL1. https://t.co/dlx2P2v1mO
A good day to also bring attention to healthcare professionals in the diaspora working to bring specialist care to Nigerians. Wrote about one, @KidneySolutionz here - https://t.co/GssfrEt7Wx #WorldKidneyDay
#DidYouKnow APOL1-mediated #KidneyDisease (AMKD) is a genetic form of kidney disease that impacts people of African ancestry? Learn more and see if you could be at risk for developing AMKD at https://t.co/R37KMAmVIn #PowerForwardTogether
A podcast from Bloomberg talking about how science has evolved for sickle cell and APOL1 mediated kidney disease- 2 diseases that have plagued Africans for eons https://t.co/85hdJFx6Tx @docneto@MANSAG_uk@anpanational@nighealthwatch
A podcast from Bloomberg talking about how science has evolved for sickle cell and APOL1 mediated kidney disease- 2 diseases that have plagued Africans for eons https://t.co/85hdJFx6Tx @docneto@MANSAG_uk@anpanational@nighealthwatch
Today launched the new AKF APOL1-Mediated #KidneyDisease Campaign to #educate & increase awareness of APOL1-mediated #CKD, a spectrum of renal diseases associated with #mutations or variants in the apolipoprotein L1 (APOL1) gene. https://t.co/ke1OyQSeKG @VertexPharma
How does #KidneyDisease relate to the APOL1 gene? Dr. Cremisi responds to questions in this Q&A blog post, supported by @VertexPharma Medical Affairs, about the Apolipoprotein L1 (APOL1) gene.
Click here to read the full Q&A: https://t.co/0uce5qnheJ